- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06400667
Functional Assessment Protocol for the Upper Limb for Pediatric Age
April 9, 2026 updated by: IRCCS Eugenio Medea
Development of New Multifactorial Functional Assessment Protocols and Related Indices for Pediatric Age -Functional Assessment Protocol for the Upper Limb
During data acquisition a trained therapist placed reflective markers on the skin of the participants in the selected body landmarks.
The participants will be asked to perform five trial for each upper limb of a determinate functional task for each session.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
Acquired brain injuries (ABIs)and cerebral palsy (CP) can lead to a wide range of impairments, including weakness or paralysis on one side of the body known as hemiplegia.
In hemiplegic patients, the rehabilitation of the upper limb skills is crucial, because the recovery has an immediate impact on patient quality of life.
Therefore, an accurate upper limb motion analysis may be useful during medical diagnostic-therapeutic process, it is relevant to understand the integrated and synergic motion of the upper limbs for a variety of applications, such as clinical diagnosis, endoprosthesis design, and the evaluation of treatment outcomes.
There are many clinical scales used to assess the upper extremity.
Most of these use an ordinal-level scoring system, with scores assigned to the patient by the observing physician or therapist.
Another way to assess upper limb activity is through kinematics data from 3D motion capture.
Kinematics data provide an objective and quantifiable method, as well as allowing the use of several otherwise undetectable metrics: time, velocity, and joint angles.
The aim of this study is introducing a new protocol consisting of a marker set, i.e. an innovative and integrated biomechanical model of the human body for the global analysis of upper limb during functional tasks allows for a more detailed evaluation of the motor behavior and its abnormalities to better characterize the functionality of the upper, both on the sagittal, frontal and transversal plane.
The development of a new protocol of analysis requires the validation before its definitive and clinical application.
More in detail, the validation should be carried out in terms of both comparisons with reference absolute measures and the evaluation of its repeatability with healthy subjects.
Study Type
Interventional
Enrollment (Estimated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Lecco
-
Bosisio Parini, Lecco, Italy, 23842
- IRCCS E. Medea
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
For healthy group:
Inclusion Criteria:
- absence of functional impairments in the upper limbs
Exclusion Criteria:
- behavioral, visual or auditory problems
- presence of pain in the upper limbs
For pathological group:
Inclusion Criteria:
- Unilateral PCI candidates for CIMT (Constraint Induced Movement Therapy) treatment;
- Acquired brain injury candidates for CIMT or Bimanual treatment;
- Ability to understand and follow test instructions.
Exclusion Criteria:
- behavioral, visual or auditory problems
- presence of pain in the upper limbs
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Healthy subjects
Subjects without upper limb disease
|
All measurements will be obtained using an optoelectronic multicamera system for human motion analysis (with eight high-resolution cameras with infrared light and a sampling frequency of 60 Hz.
The experimental protocol require the positioning of markers (plastic spheres covered by reflecting film, 10 mm in diameter).
Markers will be placed by clinical operators (physiotherapists with training in optoelectronic system for human motion analysis) after training and experience in recognition of the position of body landmarks.
During the data acquisition protocol, the subject perform five trial for each upper limb of a determinate functional task for each session.
Every subject repeat this operations 2 times with 2 different operators.
|
|
Experimental: Pathological subjects
Subjects with a brain injury like cerebral phalsy or acquired brain injury
|
All measurements will be obtained using an optoelectronic multicamera system for human motion analysis (with eight high-resolution cameras with infrared light and a sampling frequency of 60 Hz.
The experimental protocol require the positioning of markers (plastic spheres covered by reflecting film, 10 mm in diameter).
Markers will be placed by clinical operators (physiotherapists with training in optoelectronic system for human motion analysis) after training and experience in recognition of the position of body landmarks.
During the data acquisition protocol, the subject perform five trial for each upper limb of a determinate functional task for each session.
Every subject repeat this operations 2 times with 2 different operators.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intra/Inter Operator Reliability
Time Frame: Through study completion, an average of 3 year
|
In the intra and interoperator repeatability analysis the investigators considered the correlation coefficient for the average RoM (in the 5 trials) in corresponding sessions.
In particular, the investigators referred to standard interpretation criteria: the ICC values 0.5 and 0.75 indicate moderate reliability, values between 0.75 and 0.9 indicate good reliability, and values greater than, 0.90 indicate excellent reliability
|
Through study completion, an average of 3 year
|
|
Measures accuracy analysis
Time Frame: Year 1
|
For the accuracy analysis, the comparison between the reference measures and the measure obtained with the optoelectronic system for every segment of the spine was assessed through the root mean square error.
|
Year 1
|
|
Usability assessment
Time Frame: Through study completion, an average of 3 year
|
About the usability assessment, the System Usability Scale (SUS) collected at the end of each acquisition and calculated the average score value.
The SUS provides a reliable tool for measuring the usability.
The SUS questionnaire consists of a 10 item questionnaire with five response options for respondents; from Strongly agree to Strongly disagree
|
Through study completion, an average of 3 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Giuseppe Andreoni, IRCCS E. Medea - La Nostra Famiglia
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 18, 2023
Primary Completion (Estimated)
May 18, 2026
Study Completion (Estimated)
May 18, 2026
Study Registration Dates
First Submitted
March 19, 2024
First Submitted That Met QC Criteria
May 3, 2024
First Posted (Actual)
May 6, 2024
Study Record Updates
Last Update Posted (Actual)
April 14, 2026
Last Update Submitted That Met QC Criteria
April 9, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 1054
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Child
-
The Hospital for Sick ChildrenAga Khan University; March of DimesCompletedChild Development | Child Mortality | Child Morbidity | Child BehaviourPakistan
-
Boston Medical CenterCenter for the Study of Social PolicyCompletedChild Abuse | Parenting | Child Development | Child Rearing | Child NeglectUnited States
-
University of Southern CaliforniaSafe Water and AIDS Project; Early Childhood Development Network for Kenya...Active, not recruitingChild Behavior | Child Development | Language, ChildKenya
-
Windward Islands Research and Education FoundationGrand Challenges Canada; St. George's University; GRENCASECompletedDevelopment, Child | Behavior, Child | Neurocognition, ChildGrenada
-
Oral Health Centre of Expertise in Western NorwayOral Health Center of Expertise Rogaland, Norway; Childrens advocacy center... and other collaboratorsRecruitingChild Abuse | Child Neglect | Child MaltreatmentNorway
-
South London and Maudsley NHS Foundation TrustCarol Hardy, Research Lead, South London and Maudsley NHS FoundationCompletedChild Development | Parent Child Relationships | Parent Child InteractionsUnited Kingdom
-
University of South CarolinaCompletedParents | Child Behavior | Child Health | Child, PreschoolUnited States
-
Oral Health Centre of Expertise in Western NorwayEducational storytelling forlag og filmCompletedChild Abuse | Oral Health | Child Neglect | Child Maltreatment | Child Sexual Abuse | Dental NeglectNorway
-
Buzzi Children's HospitalNot yet recruitingChild Abuse | Child Neglect | Child Maltreatment
-
The Hospital for Sick ChildrenRecruitingParenting | Early Child Development | Child Nutrition | Child Eating BehavioursCanada
Clinical Trials on Upper limb Kinematic Assessment with Optoelectronic system
-
IRCCS Eugenio MedeaActive, not recruiting
-
KU LeuvenUniversitaire Ziekenhuizen KU Leuven; Vrije Universiteit BrusselRecruiting
-
Vastra Gotaland RegionPromobilia FoundationNot yet recruitingSpinal Cord Injuries (SCI) | Upper Limb Function
-
Riphah International UniversityRecruiting
-
MTI UniversityCompleted
-
Holland Bloorview Kids Rehabilitation HospitalCanadian Institutes of Health Research (CIHR)Recruiting
-
Swiss Federal Institute of TechnologyKliniken Valens, Rehazentrum Valens, Taminaplatz 1, 7317 ValensCompletedAssessment of Arm and Hand Sensorimotor Functions in Multiple Sclerosis SubjectsSwitzerland
-
Enio Walker Azevedo CachoFundação de Amparo à Pesquisa do Estado de São PauloCompletedTetraplegia | Tetraparesis
-
University of AlcalaCompletedCancer | Shoulder Pain | RehabilitationSpain
-
Cairo UniversityCompletedCerebral PalsyEgypt